Navigation Links
HIV Vaccine Field Trials In Advanced Stage

Field trials of a HIV vaccine developed in the US are at an advanced stage but it could be a while before it is made available to the public, says an expert involved in the project. //

"You must appreciate that this is a huge effort. There are large numbers of people involved and we have to be very careful with our testing methods. We are on the way but it will be a while before the vaccine is commercially available," said Maj. Gen. Eric Schoomaker, commander of the US Army Medical Research and Material Command.

He was speaking at a session on HIV/AIDS on the second day of the 16th Asia-Pacific Military Medicine Conference here.

The vaccine was developed under the US Military HIV Research Programme. It is currently being tested in the US and Thailand and the trials will expand to East Africa in 2007, Schoomaker stated.

The trials, designed to answer the question of whether or not the vaccine is effective in preventing HIV infection, can take three to five years to complete, he explained.

Human trials of other vaccines are also being carried out in countries like China and South Africa but have not yet proved to be significantly effective against HIV.

Detailing the efforts of the Indian armed forces in preventing and controlling HIV, Col. A.K. Verma of the Army Medical Corps (AMC) said every effort was being made to "retain" all positive cases to avoid stigma and discrimination.

"As a result, it has been possible to stem the incidence of HIV in the services," he added.

HIV incidence in the armed forces is a mere .028 percent against a national average of .9 percent. The incidence is .026 percent in the US armed forces, largely due to compulsory screening at the entry stage. India is now mulling a similar move.

According to Col. Verma, 92 Information, Education and Communication (IEC) modes had been established all over the country to spread awareness about the disease, while immunodeficiency centres have also been set up to administer antiretroviral therapy drugs to the patients and their families.

More than 40 million people around the world have been infected by HIV/AIDS and some 25 million people have died.

--Edited IANS
'"/>




Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... 2016 , ... National recruitment firm Slone Partners is pleased to ... genomics experience, as Vice President of North American Capital Sales at HTG Molecular ... the sales team in the commercialization of the HTG EdgeSeq system and associated reagents ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: